KCM
CEMI

Kennedy Capital Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Kennedy Capital Management’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-570,113
Closed -$1.85M – 706
2020
Q2 		$1.85M Buy
+570,113
New +$5.41M 0.05% 508

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Kennedy Capital Management's CEMI Position: Q3 2020 in Review

Kennedy Capital Management sold out of Chembio diagnostics, Inc. (CEMI) in Q3 2020, closing a stake of 570,113 shares — an estimated $1.85M sold.

Kennedy Capital Management first reported a position in CEMI in Q2 2020 and held it in 1 quarter. The position peaked at $1.85M in Q2 2020. 59 funds tracked by Wall St. Rank hold CEMI as of Q3 2020.

  • Kennedy Capital Management reported no remaining Chembio diagnostics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Kennedy Capital Management sold 570,113 Chembio diagnostics, Inc. shares in Q3 2020, an estimated $1.85M.
  • Kennedy Capital Management first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 1 quarter.
  • Kennedy Capital Management's Chembio diagnostics, Inc. position peaked at $1.85M in Q2 2020.
  • 59 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2020.

Based on Kennedy Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.